157 related articles for article (PubMed ID: 37133326)
1. Luminex Crossmatch in kidney transplantation.
Ameur RF; Berkani LM; Belaid B; Habchi K; Saidani M; Djidjik R
Scand J Immunol; 2023 Jul; 98(1):e13279. PubMed ID: 37133326
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of Luminex-based donor-specific antibody mean fluorescence intensity values with complement-dependent cytotoxicity & flow crossmatch results in live donor renal transplantation.
Baranwal AK; Bhat DK; Goswami S; Agarwal SK; Kaur G; Kaur J; Mehra N
Indian J Med Res; 2017 Feb; 145(2):222-228. PubMed ID: 28639599
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Rapid Optimized 96-well Tray Flow Cytometric Crossmatch (Halifax-FCXM) with Luminex Single Antigen Test.
Yoo J; Lee S; Lee HW; Lee S; Choi J; Han J; Kang H; Choi A; Hee Jang J; Oh EJ
Hum Immunol; 2021 Apr; 82(4):302-308. PubMed ID: 33744026
[TBL] [Abstract][Full Text] [Related]
4. The good, the bad, and the ugly of luminex donor-specific crossmatch.
Chowdhry M; Makroo RN; Thakur Y; Sharma V; Singh M; Kumar M
HLA; 2018 Jun; 91(6):501-506. PubMed ID: 29457879
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
Billen EV; Christiaans MH; van den Berg-Loonen EM
Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
[TBL] [Abstract][Full Text] [Related]
6. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
7. Luminex donor-specific crossmatches.
Billen EV; Voorter CE; Christiaans MH; van den Berg-Loonen EM
Tissue Antigens; 2008 Jun; 71(6):507-13. PubMed ID: 18380779
[TBL] [Abstract][Full Text] [Related]
8. Impact of pre-transplant donor specific antibodies detected by Luminex with negative microlymphocytotoxicity assay and flow crossmatch in live-related renal transplant recipients.
Abbas K; Aziz T; Musharaf W; Mubarak M; Zafar MN
Clin Transplant; 2023 May; 37(5):e14935. PubMed ID: 36799009
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
[TBL] [Abstract][Full Text] [Related]
10. Predicting flow cytometry crossmatch results from single-antigen bead testing.
Flynn PA; Fernando S; Worthington JE; Poulton KV
Int J Immunogenet; 2024 Apr; 51(2):93-99. PubMed ID: 38374539
[TBL] [Abstract][Full Text] [Related]
11. Significance of Luminex-based single antigen class II bead assay and its mean fluorescence intensity in renal transplant cases; a retrospective observation in 97 cases.
Pande A; Pandey P; Kumar Devra A; Kumar Sinha V; Prasad Bhatt A
J Immunoassay Immunochem; 2020 May; 41(3):322-336. PubMed ID: 32122239
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
Olszowska-Zaremba N; Gozdowska J; Zagożdżon R
Transpl Immunol; 2022 Oct; 74():101672. PubMed ID: 35868613
[TBL] [Abstract][Full Text] [Related]
13. Correlation of Luminex-Based Single Antigen Based Results With Complement-Dependent Cytotoxicity Crossmatch and Flow Cytometry Crossmatch Results: A Single-Center Experience From Istanbul.
Oguz SR; Sinangil A; Barlas S; Ciftci HS; Ulusoy E; İzgi DK; Ogret Y; Ecder T; Akin B
Transplant Proc; 2023 Mar; 55(2):303-308. PubMed ID: 36890054
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of complement-dependent lymphocytotoxicity crossmatch and flow cytometry crossmatch results versus Luminex single-antigen bead-based donor-specific IgG class I antibody MFI values in live related renal transplant cases; a retrospective observation in 102 cases.
Pandey P; Pande A; Kumar Devra A; Kumar Sinha V; Prasad Bhatt A
J Immunoassay Immunochem; 2021 May; 42(3):300-313. PubMed ID: 33356865
[TBL] [Abstract][Full Text] [Related]
15. Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation.
Morris GP; Phelan DL; Jendrisak MD; Mohanakumar T
Hum Immunol; 2010 Mar; 71(3):268-73. PubMed ID: 20074605
[TBL] [Abstract][Full Text] [Related]
16. Antibody monitoring system to support the single-antigen Luminex assay in donor-specific antibody detection.
Hwang HS; Sun IO; Yoon HE; Choi BS; Oh EJ; Kim JI; Moon IS; Kim YS; Yang CW
Hum Immunol; 2012 Apr; 73(4):370-5. PubMed ID: 22342452
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Panel Reactive Antibodies in Renal Transplant Recipients Detected by Luminex: A Single-Center Experience.
İnal A; Özçelik Ü; Ogan Uyanık E; Külah E; Demirağ A
Exp Clin Transplant; 2016 Aug; 14(4):401-4. PubMed ID: 26517205
[TBL] [Abstract][Full Text] [Related]
18. Comparative performance evaluation of a donor-specific bead-based crossmatch technique for the detection of donor-specific anti-HLA antibodies in heart transplantation.
Chaidaroglou A; Skoura A; Degiannis D
Transplant Proc; 2013 Jun; 45(5):2005-8. PubMed ID: 23769095
[TBL] [Abstract][Full Text] [Related]
19. Rapid optimized flow cytometric crossmatch (FCXM) assays: The Halifax and Halifaster protocols.
Liwski RS; Greenshields AL; Conrad DM; Murphey C; Bray RA; Neumann J; Gebel HM
Hum Immunol; 2018 Jan; 79(1):28-38. PubMed ID: 29109009
[TBL] [Abstract][Full Text] [Related]
20. Donor-specific HLA antibodies in predicting crossmatch outcome: Comparison of three different laboratory techniques.
Peräsaari JP; Jaatinen T; Merenmies J
Transpl Immunol; 2018 Feb; 46():23-28. PubMed ID: 29157597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]